News about "Emcure Pharmaceuticals "

Emcure Pharma Delivers Robust Performance Across All Businesses in Q1FY26: Satish Mehta

Emcure Pharma Delivers Robust Performance Across All Businesses in Q1FY26: Satish Mehta

Emcure Pharmaceuticals reported strong financial results for the first quarter of FY26, demonstrating impressive growth in both domestic and international businesses.

Emcure Pharmaceuticals | 07/08/2025 | By Dineshwori 265

Sanofi India, Emcure Sign Exclusive Distribution Partnership for Anti-Diabetic Drugs

Sanofi India, Emcure Sign Exclusive Distribution Partnership for Anti-Diabetic Drugs

Sanofi India Ltd. has entered into an exclusive distribution and promotion agreement with Emcure Pharmaceuticals for its oral anti-diabetic brands, including Amaryl and Cetapin, aiming to expand patient access and strengthen diabetes care across India.

Emcure Pharmaceuticals | 17/07/2025 | By Mrinmoy Dey 194

Emcure Pharma Taps Industry Veteran R.S. Vasan to Lead India Business

Emcure Pharma Taps Industry Veteran R.S. Vasan to Lead India Business

Emcure Pharmaceuticals Ltd. has appointed R.S. Vasan as President – India Business and Senior Management Personnel (SMP).

Emcure Pharmaceuticals | 16/07/2025 | By Dineshwori 233

Emcure Pharmaceuticals Launches its R&D Centre in Ahmedabad

Emcure Pharmaceuticals Launches its R&D Centre in Ahmedabad

The Emcure Research Centre (ERC) is strategically designed to enable breakthroughs in complex drug delivery systems, such as sustained-release formulations, liposomal injections and advanced dermal therapies.

Emcure Pharmaceuticals | 23/01/2025 | By Aishwarya 581

Emcure Launches New Entity Emcutix Biopharmaceuticals for Dermatology Sector

Emcure Launches New Entity Emcutix Biopharmaceuticals for Dermatology Sector

As a part of this strategic initiative, Emcure's existing dermatology business will also operate under Emcutix.

Emcure Pharmaceuticals | 29/10/2024 | By Aishwarya 703

Emcure Plans for Expansion and New Acquisitions with Upcoming IPO

Emcure Plans for Expansion and New Acquisitions with Upcoming IPO

Emcure Pharmaceuticals has been planning to expand its business as the upcoming initial public offering (IPO) will give the company access to new growth capital which it will use to fund inorganic growth and explore acquisitions.

Emcure Pharmaceuticals | 29/06/2024 | By Aishwarya 1243


 

 

We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.

More information: Privacy Policy

 pharmaindustrial-india.com - Professional magazine for pharma industry suppliers and lab technology - CEDRO members